نتایج جستجو برای: memantine

تعداد نتایج: 1420  

2017
Martin Knapp Derek King Renée Romeo Jessica Adams Ashley Baldwin Clive Ballard Sube Banerjee Robert Barber Peter Bentham Richard G Brown Alistair Burns Tom Dening David Findlay Clive Holmes Tony Johnson Robert Jones Cornelius Katona James Lindesay Ajay Macharouthu Ian McKeith Rupert McShane John T O'Brien Patrick P J Phillips Bart Sheehan Robert Howard

OBJECTIVE Most investigations of pharmacotherapy for treating Alzheimer's disease focus on patients with mild-to-moderate symptoms, with little evidence to guide clinical decisions when symptoms become severe. We examined whether continuing donepezil, or commencing memantine, is cost-effective for community-dwelling, moderate-to-severe Alzheimer's disease patients. METHODS Cost-effectiveness ...

2015
Sheng-Yu Lee Shiou-Lan Chen Yun-Hsuan Chang Po See Chen San-Yuan Huang Nian-Sheng Tzeng Liang-Jen Wang I Hui Lee Tzu-Yun Wang Kao Chin Chen Yen Kuang Yang Jau-Shyong Hong Ru-Band Lu

Low-dose memantine might have anti-inflammatory and neurotrophic effects mechanistically remote from an NMDA receptor. We investigated whether add-on memantine reduced cytokine levels and benefitted patients with opioid dependence undergoing methadone maintenance therapy (MMT) in a randomized, double-blind, controlled 12-week study. Patients were randomly assigned to a group: Memantine (5 mg/da...

Journal: :Journal of substance abuse treatment 2014
Adam Bisaga Maria A Sullivan Andrew Glass Kaitlyn Mishlen Kenneth M Carpenter John J Mariani Frances R Levin Edward V Nunes

There is preclinical support for using NMDA receptor glutamatergic antagonists to aid in naltrexone-based treatment of opioid dependence. We hypothesized that adding memantine will improve efficacy of extended-release (XR) naltrexone to prevent relapse. In this double blind study opioid-dependent participants (N=82) underwent inpatient detoxification and naltrexone induction. During naltrexone ...

Journal: :Journal of cognitive neuroscience 2013
Benjamin Becker Eva M. Klein Nadine Striepens Yoan Mihov Thomas E. Schlaepfer Juergen Reul Liesbet Goossens Koen Schruers Keith M. Kendrick René Hurlemann

Hippocampal learning is thought to induce metaplasticity, which can facilitate subsequent learning. Administered at single low doses, the N-methyl-d-aspartate-type glutamate receptor antagonist memantine predominantly blocks α7 nicotinic acetylcholine receptors (α7 nAChRs). Placebo-controlled administration of a single low dose of memantine in a pharmaco-fMRI experiment may thus help characteri...

2013
Caroline Moreau Arnaud Delval Vincent Tiffreau Luc Defebvre Kathy Dujardin Alain Duhamel Gregory Petyt Claude Hossein-Foucher David Blum Bernard Sablonnière Susanna Schraen Delphine Allorge Alain Destée Régis Bordet David Devos

BACKGROUND Given that memantine is thought to decrease N-methyl-D-aspartic-acid-related (NMDA) glutamatergic hyperactivity and improve locomotion in rats, we sought to assess the drug's impact on axial symptoms in advanced Parkinson's disease (PD). METHODS We performed a 90-day, randomised, double-blind, study with two parallel arms: 20 mg/day memantine versus placebo (ClinicalTrials.gov:NCT0...

2011
LAURIAN VLASE MARCELA ACHIM DANA MUNTEAN ADRIAN GAL CORNEL CĂTOI CONSTANTIN BODOLEA SORIN E. LEUCUŢA

A pharmacokinetic study of intravenously and orally administered memantine was run on 12 pigs. The blood samples were collected up to 12 hours after drug administration. The memantine plasma levels were determined using a validated method of liquid chromatography coupled with mass spectrometry detection. Six pharmacokinetic models were screened and the best one describing the absorption and dis...

Journal: :Neuropsychiatric Disease and Treatment 2007
Rajesh R Tampi Christopher H van Dyck

Alzheimer's disease (AD) is the most common cause of dementia, accounting for 25 million cases worldwide. Until recently, the pharmacotherapy of AD was limited to the use of cholinesterase inhibitors (ChEIs) that are approved only for the mild to moderate stages of the illness. Memantine, an NMDA receptor antagonist has been found to be effective, both as monotherapy and in combination with don...

Journal: :Pharmacological reports : PR 2014
Renny Abraham Ramakrishna Nirogi Anil Shinde

BACKGROUND It is a well-known fact that 5HT6 ligands increase glutamate levels. In the current study we investigated whether a 5HT6 antagonist, SB399885 would show antidepressant like property at a dose which would significantly increase the glutamate levels. Further we studied if the combination of a 5HT6 antagonist and N-methyl-D-aspartate (NMDA) antagonist, memantine would restore the antide...

2012
Susanne Hartz Denis Getsios Sunning Tao Steve Blume Grant Maclaine

BACKGROUND Previous cost-effectiveness studies of cholinesterase inhibitors have modeled Alzheimer's disease (AD) progression and treatment effects through single or global severity measures, or progression to "Full Time Care". This analysis evaluates the cost-effectiveness of donepezil versus memantine or no treatment in Germany by considering correlated changes in cognition, behavior and func...

Journal: :Investigative ophthalmology & visual science 2004
William A Hare Elizabeth WoldeMussie Ronald K Lai Hau Ton Guadalupe Ruiz Teresa Chun Larry Wheeler

PURPOSE To determine, using electrophysiological measures of visual system function, whether oral daily dosing of memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates. METHODS Argon laser treatment of the anterior chamber angle was used to induce chronic ocular hypertension (COHT) in the right eye of 18 macaque monkeys. Nine animals were ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید